A Cross-Sectional Observational Study of Non-alcoholic Fatty Liver Disease Assessed by Fibrosis Index in Patients With Type 2 Diabetes Mellitus Presenting to a Tertiary Care Centre in Southwestern Maharashtra - Cureus

A recent cross-sectional study out of Southwestern Maharashtra has revealed an alarmingly high prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) with advanced fibrosis among patients with Type 2 Diabetes Mellitus (T2DM). The findings, published in Cureus, underscore a rapidly escalating public health crisis in India, demanding immediate attention to integrated screening and management strategies to avert widespread liver complications. This new data intensifies calls from the Indian Council of Medical Research (ICMR) for a national screening strategy, as current diagnostic protocols frequently miss early-stage NAFLD, which can silently progress to cirrhosis. With India already battling one of the world's largest T2DM populations, the convergence of uncontrolled diabetes and progressive liver disease threatens to overwhelm healthcare infrastructure, especially tertiary care centre. The significant economic burden of advanced liver disease, including potential transplants, poses a daunting long-term fiscal challenge for state health departments like Maharashtra. Health officials, particularly within the Public Health Department of Maharashtra, are now under immense pressure to expedite pilot programs for non-invasive NAFLD screening within existing diabetes management frameworks. The focus will be on leveraging tools such as the Fibrosis Index (e.g., FIB-4) and Transient Elastography to identify high-risk patients earlier. The outcomes of these localized initiatives will be critical in shaping future national guidelines and resource allocation, aiming to stem the tide of preventable liver morbidity across the subcontinent.